logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Akira Abe

This inventor holds 7 USPTO granted patents and 2 EPO patents. Top assignee: University of Michigan. Active years: 2008-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Abe. Retrieved from https://idiyas.com/inventor/akira-abe-rzjos8lo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal7 out of 3,546 
 
University of Michigan
 patents

Years Active: 2008-2019

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 10202340 - Glucosylceramide synthase inhibitors and therapeutic methods using the same (2019-02-12),
2. 10111937 - Method of reducing accumulation of intracellular tingible body macrophages (2018-10-30),
3. 9309553 - Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus (2016-04-12),
4. 8961959 - Glucosylceramide synthase inhibitors and therapeutic methods using the same (2015-02-24),
5. 8052970 - Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis (2011-11-08),
6. 7582442 - Methods and compositions for using aleveolar macrophage phospholipase A2 (2009-09-01),
7. 7319015 - Methods and compositions for using alveolar macrophage phospholipase A2 (2008-01-15),

Title: Akira Abe: Innovator in Therapeutic Methods

Introduction

Akira Abe is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of therapeutic methods, particularly in the treatment of various diseases. With a total of 7 patents to her name, her work has had a substantial impact on medical science.

Latest Patents

Among her latest patents, Akira Abe has developed glucosylceramide synthase inhibitors and therapeutic methods using the same. These inhibitors and compositions are disclosed for their potential in treating diseases such as Gaucher disease and Fabry disease. Additionally, she has created methods for reducing the accumulation of intracellular tingible body macrophages. This invention focuses on the diagnosis and treatment of systemic lupus erythematosus and drug-induced systemic lupus erythematosus, utilizing a lysosomal phospholipase A2.

Career Highlights

Akira Abe is affiliated with the University of Michigan, where she continues her research and innovation. Her work has been instrumental in advancing therapeutic approaches for autoimmune disorders and other medical conditions.

Collaborations

She has collaborated with notable colleagues, including James A Shayman and Robert Kelly, further enhancing the scope and impact of her research.

Conclusion

Akira Abe's contributions to the field of therapeutic methods exemplify her dedication to improving healthcare through innovation. Her patents reflect a commitment to addressing complex medical challenges, making her a valuable figure in the realm of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…